RxDoctor Payments Data

Amy Rivere, MD

Surgical Oncology · New Orleans, LANPI 1801115803

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 50.2% of the total. Reporting peaked in 2024 at $1,611 and has fallen 71.0% since, to $467 in 2025.

$3,641in general payments, 2019–2025

Across 81 payments — averaging $44.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Myriad Genetic Laboratories, Inc.$435
  • KUB Technologies Inc.$402
  • Sientra, Inc.$340
  • Vector Surgical, LLC$300
  • Olympus America Inc.$98
  • plus $238 from 8 others

What the payments were for

  • Food & beverage$3,641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)50$1,829
Myriad Genetic Laboratories, Inc.11$435
KUB Technologies Inc.4$402
Sientra, Inc.2$340
Vector Surgical, LLC1$300
Olympus America Inc.1$98
Axogen2$60
Baxter Healthcare2$50
Merit Medical Systems Inc3$40
Focal Therapeutics, Inc.1$29
Endomagnetics Ltd1$18
Mallinckrodt Enterprises LLC1$14
Tactile Systems Technology Inc1$14
AstraZeneca1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,641 in reported general payments places this provider in the 65th percentile of 26 surgical oncology providers in Louisiana.

See all surgical oncology providers in Louisiana

Medicare billing

Part B allowed, 2024
$38,402
Medicare patients
67
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →